Nebenwirkungen · Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka)
Lenalidomide Krka d.d. Novo mesto 2.5 mg hard capsules Lenalidomide Krka d.d. Novo mesto 5 mg hard capsules Lenalidomide Krka d.d. Novo mesto 7.5 mg hard capsules Lenalidomide Krka d.d. Novo mesto 10 mg hard capsules Lenalidomide Krka d.d. Novo mesto 15 mg hard capsules Lenalidomide Krka d.d. Novo mesto 20 mg hard capsules Lenalidomide Krka d.d. Novo mesto 25 mg hard capsules · Abschnitt 4.8 · PDF-Seite 26
HOS-148798 · Präparat HOS-099972
Common Uncommon Reduced visual acuity Blindness Ear and Labyrinth Common Disorders Deafness (Including Hypoacusis), Tinnitus Cardiac Disorders Common Common Atrial fibrillation◊,◊◊, Bradycardia Myocardial infarction (including acute)^,◊, Atrial fibrillation◊,◊◊, Uncommon Congestive cardiac failure◊, Arrhythmia, QT prolongation, Atrial Tachycardia, Cardiac failure◊,◊◊, flutter, Ventricular extrasystoles Myocardial ischemia◊ Vascular Disorders Very common Very common Venous thromboembolic events^, Venous thromboembolic events^, predominantly deep vein thrombosis and predominantly deep vein pulmonary embolism^,◊,◊◊, Hypotension◊◊ thrombosis and pulmonary embolism^ ,◊,◊◊ Common Hypertension, Ecchymosis^ Common Vasculitis, Hypotension◊◊, Hypertension
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2021-12-17T12:56:00Z · SHA-256 9b15721a878f6b48caf8691524d0cc634862d39053d4ce108521191ff1511e31 · Passage 6cd5f64659419bd8957f3b11f7256f282a4c48d4fe8ed2d86466c6332405b05c · Zeichen 17793–19259 im Abschnitt